Association between the Use of Statins and Brain Tumors

This study aimed to investigate the effects of statin use on incidence brain tumors. The Korean National Health Insurance Service—National Sample Cohort from 2005 2019 was used. 1893 patients who were diagnosed with tumors matched 7572 control for demographic variables. history dyslipidemia collected, and their prescription statins before diagnosis tumor examined. participants without set as a reference population. Then, odds analyzed in use, prescribed less than 365 days, days or more. Propensity score overlap weighted multivariable logistic regression analysis used adjusted demographics comorbidities. Secondary analyses conducted according types statins, malignancy tumors, histories A total 11.78% 10.95% had Dyslipidemia more duration demonstrated 1.22 times higher normal (95% confidence intervals [CI] = 1.06–1.14, p 0.007). other groups (odds ratio 1.60, 95% CI 1.36–1.87, < 0.001). short-term users (<365 days) long-term (≥365 consistent secondary Long-term related lower risk dyslipidemia.